| 1 | 1380082 | Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro. | J Pharmacol Exp Ther | 1992 Aug |
5 |
| 2 | 2460616 | Biochemical profile of risperidone, a new antipsychotic. | J Pharmacol Exp Ther | 1988 Nov |
1 |
| 3 | 2481562 | Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography. | Brain Res | 1989 Oct 23 |
1 |
| 4 | 2484825 | The efficacy of the D2 and 5-HT2 antagonist risperidone (R 64,766) in the treatment of chronic psychosis. An open dose-finding study. | Schizophr Res | 1989 Jul-Oct |
1 |
| 5 | 7504573 | Pharmacological profile of risperidone. | Can J Psychiatry | 1993 Sep |
1 |
| 6 | 7508329 | Dopamine D2 receptor occupancy in vivo and response to the new antipsychotic risperidone. | Br J Psychiatry | 1993 Dec |
1 |
| 7 | 7512019 | The metabolism and excretion of risperidone after oral administration in rats and dogs. | Drug Metab Dispos | 1994 Jan-Feb |
2 |
| 8 | 7516078 | In vivo dopamine-D2 and serotonin-5-HT2 receptor binding study of risperidone and haloperidol. | Pharmacol Biochem Behav | 1994 Mar |
1 |
| 9 | 7520904 | Efficacy of risperidone on positive features of schizophrenia. | J Clin Psychiatry | 1994 May |
1 |
| 10 | 7520908 | Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. | J Clin Psychiatry | 1994 May |
3 |
| 11 | 7527327 | Risperidone. A review of its pharmacology and therapeutic potential in the treatment of schizophrenia. | Drugs | 1994 Aug |
1 |
| 12 | 7530204 | Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone. | Eur J Pharmacol | 1994 Oct 13 |
1 |
| 13 | 7530376 | 5-HT2 and D2 dopamine receptor occupancy in the living human brain. A PET study with risperidone. | Psychopharmacology (Berl) | 1993 |
3 |
| 14 | 7530377 | Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors. | Psychopharmacology (Berl) | 1993 |
1 |
| 15 | 7531353 | Survey on the pharmacodynamics of the new antipsychotic risperidone. | Psychopharmacology (Berl) | 1994 Feb |
2 |
| 16 | 7532732 | Effects of risperidone on phencyclidine-induced behaviors: comparison with haloperidol and ritanserin. | Jpn J Pharmacol | 1994 Oct |
2 |
| 17 | 7536945 | Dopamine D2 receptor blockade in vivo with the novel antipsychotics risperidone and remoxipride--an 123I-IBZM single photon emission tomography (SPET) study. | Psychopharmacology (Berl) | 1995 Jan |
1 |
| 18 | 7540803 | Risperidone-induced prolactin elevations in premenopausal women with schizophrenia. | Am J Psychiatry | 1995 Jul |
1 |
| 19 | 7542051 | Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study. | Eur Neuropsychopharmacol | 1995 Mar |
2 |
| 20 | 7543969 | The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. | Life Sci | 1995 |
1 |
| 21 | 7545821 | A PET study of D2 and 5-HT2 receptor occupancy induced by risperidone in poor metabolizers of debrisoquin and risperidone. | Psychopharmacology (Berl) | 1995 Jun |
4 |
| 22 | 7690693 | Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects. | Clin Pharmacol Ther | 1993 Sep |
1 |
| 23 | 7691623 | Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors. | Eur J Pharmacol | 1993 Jul 20 |
3 |
| 24 | 7898773 | Competitive antagonism of serotonin (5-HT)2C and 5-HT2A receptor-mediated phosphoinositide (PI) turnover by clozapine in the rat: a comparison to other antipsychotics. | Neurosci Lett | 1994 Nov 7 |
2 |
| 25 | 7965768 | Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. | J Pharmacol Exp Ther | 1994 Nov |
1 |
| 26 | 8542328 | Acute administration of typical and atypical antipsychotic drugs induces distinctive patterns of Fos expression in the rat forebrain. | Brain Res | 1995 Aug 7 |
2 |
| 27 | 8570027 | The interactions of typical and atypical antipsychotics with the (-)2, 5,-dimethoxy-4-methamphetamine (DOM) discriminative stimulus. | Neuropharmacology | 1995 Oct |
2 |
| 28 | 8587922 | Mixed D2/5-HT2A antagonism of amphetamine-induced facilitation of brain stimulation reward. | Pharmacol Biochem Behav | 1995 Dec |
1 |
| 29 | 8595204 | Risperidone does not elevate neurotensin mRNA in rat nucleus accumbens and caudate-putamen. | Neuroreport | 1995 Nov 13 |
1 |
| 30 | 8597525 | Differential regulation of rat 5-HT2A and 5-HT2C receptors after chronic treatment with clozapine, chlorpromazine and three putative atypical antipsychotic drugs. | Neuropsychopharmacology | 1995 Oct |
2 |
| 31 | 8666572 | Risperidone augmentation of SRI treatment for refractory obsessive-compulsive disorder. | J Clin Psychiatry | 1996 Jul |
3 |
| 32 | 8748391 | Influence of age, renal and liver impairment on the pharmacokinetics of risperidone in man. | Psychopharmacology (Berl) | 1995 Dec |
2 |
| 33 | 8749037 | Reversal of dizocilpine-induced disruption of prepulse inhibition of an acoustic startle response by the 5-HT2 receptor antagonist ketanserin. | Eur J Pharmacol | 1995 Dec 12 |
1 |
| 34 | 8823349 | New developments in the pharmacologic treatment of schizoaffective disorder. | J Clin Psychiatry | 1996 |
1 |
| 35 | 8925876 | In functional experiments, risperidone is selective, not for the B, but for the A subtype of alpha 1-adrenoceptors. | Eur J Pharmacol | 1996 Jan 4 |
1 |
| 36 | 8927657 | Serotonin-mediated increase in cytosolic [Ca++] in platelets of risperidone-treated schizophrenia patients. | Psychopharmacol Bull | 1996 |
1 |
| 37 | 8935801 | Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. | Psychopharmacology (Berl) | 1996 Mar |
5 |
| 38 | 8941167 | Pharmacokinetics and drug interactions: update for new antipsychotics. | J Clin Psychiatry | 1996 |
1 |
| 39 | 8998275 | Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs. | Schizophr Res | 1996 Jul |
1 |
| 40 | 9138438 | Adverse effects of risperidone on eye movement activity: a comparison of risperidone and haloperidol in antipsychotic-naive schizophrenic patients. | Neuropsychopharmacology | 1997 Mar |
1 |
| 41 | 9197279 | Augmentation of opioid induced antinociception by the atypical antipsychotic drug risperidone in mice. | Neurosci Lett | 1997 May 30 |
2 |
| 42 | 9220048 | Fatal cardiac event following initiation of risperidone therapy. | Ann Pharmacother | 1997 Jul-Aug |
1 |
| 43 | 9231305 | Erythromycin interaction with risperidone or clomipramine in an adolescent. | J Child Adolesc Psychopharmacol | 1996 Summer |
4 |
| 44 | 9337781 | D2 dopamine receptor occupancy: a crossover comparison of risperidone with clozapine therapy in schizophrenic patients. | Arch Gen Psychiatry | 1997 Oct |
1 |
| 45 | 9353417 | Differential regulation of D2 and D4 dopamine receptor mRNAs in the primate cerebral cortex vs. neostriatum: effects of chronic treatment with typical and atypical antipsychotic drugs. | J Pharmacol Exp Ther | 1997 Nov |
1 |
| 46 | 9393391 | Update on pharmacologic management of OCD: agents and augmentation. | J Clin Psychiatry | 1997 |
1 |
| 47 | 9422809 | Risperidone inhibits 5-hydroxytryptaminergic neuronal activity in the dorsal raphe nucleus by local release of 5-hydroxytryptamine. | Br J Pharmacol | 1997 Dec |
1 |
| 48 | 9435993 | Selective serotonin reuptake inhibitors and CNS drug interactions. A critical review of the evidence. | Clin Pharmacokinet | 1997 Dec |
1 |
| 49 | 9476970 | Mixed D2/5-HT2A antagonism of cocaine-induced facilitation of brain stimulation reward. | Pharmacol Biochem Behav | 1998 Feb |
1 |
| 50 | 9477007 | Risperidone in the treatment of schizophrenia: results of a study of patients from Germany, Austria, and Switzerland. | Eur Arch Psychiatry Clin Neurosci | 1997 |
1 |